RTW Investments
Overview
RTW Investments is a life sciences investment and innovation firm that invests across the full lifecycle of biopharmaceutical and medical technology companies, from company creation to public markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Principia | Aug 2018 | Series C | Lead |
| Kailera Therapeutics | Oct 2025 | Series B | Co-investor |
| METiS Therapeutics | May 2026 | IPO | Co-investor |
| ARVION | Nov 2023 | Private Placement | Lead |
| Numab Therapeutics | Jan 2025 | Series C Extension | Co-investor |
For institutional investors. Book with your work email.
Key People
Rebecca Velez Frey
Venture Partner
gotham makker
Partner
Joshua Kennedy-Smith
Partner
Simon Viergutz
Principal
Chew Thomas
Biotech Investing
Kelly Scholtz
Investor Relations
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is RTW Investments based?
RTW Investments is headquartered in New York City, New York, United States.
When was RTW Investments founded?
RTW Investments was founded in 2009.
How many portfolio companies does RTW Investments have?
RTW Investments has 57 portfolio companies in Caplight's dataset.
What are some companies in RTW Investments's portfolio?
Portfolio companies visible on Caplight include Principia, Kailera Therapeutics, METiS Therapeutics, ARVION, Numab Therapeutics.
What was RTW Investments's most recent investment shown here?
RTW Investments's most recent investment in this portfolio sample was in METiS Therapeutics in 2026.
What sectors does RTW Investments focus on?
RTW Investments focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does RTW Investments focus on?
RTW Investments typically invests at the Mid stage.
What is RTW Investments's AUM?
RTW Investments's assets under management are estimated between $1.0B and $10.0B.